GL
Monte Rosa
GLUE·NASDAQBoston MAFounded 2018100 employees
Small CapbiotechPublicOncology
Platform: MRT-6160 VAV1
Market Cap
$0.3B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (GLUE)
Loading GLUE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevirasimod | GLU-9610 | Phase 2/3 | 1 | IL-17A | RA | ||
| Ribozanubrutinib | GLU-9153 | Phase 1 | 2 | BET | RBCrohn's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)